ADCs & Cancer Immunotherapy

February 2016



Austria Trend Hotel Savoyen Vienna

Rennweg 16, 1030

About Summit

This innovative B2B event will enable the participants to learn about protein modeling development and engineering advances, preclinical and clinical improvements, current ADC linker chemistry- better linker design for future generations, improving preclinical and clinical translation and creating strong and scalable processes.

Who Should Attend

CEOs, Directors, Department Heads & Managers of Leading Application Creators & Suppliers from:

  • Discovery Chemistry
  • Antibody Discovery
  • Oncology Molecules
  • Development Analytics and New Technologies
  • Molecular Biology
  • Biotherapeutics
  • Data analysis
  • Oncology Drug Development
  • Bioanalytical
  • Clinical Assay
  • Research & Development
  • Protein Engineering
  • Biopharmaceutical Development
  • Toxicology
  • Technology
  • Molecular Medicine
  • Analytical & Formulation
  • Medical information
  • Process Sciences

From Industries Including: 

  • Pharmaceuticals, Biologics, Medicine
  • Academic Research Centers
  • Clinical Research Organizations
  • Regulatory Agencies
Key Practical Learning Points of the Summit

Increase benefits of ADC-dial in potency, target stratified patient populations and optimize dosing regimens
Ensure product and process robustness
Make more evidence-based decisions
Explore alternative opportunities for ADCs by reviewing the potential of using ADCs outside oncology
Learn about advances in protein modelling and engineering breakthroughs
How to screen for optimal site of conjugation, select better quality targets and explore new payload mechanisms of action?
Linker design decisions, novel payloads and linker technology, next-generation chemistry for improved conjugation and linker stability
Characterization of ADCs, preclinical and clinical advances, translational considerations
Engineering ADCs for developability, enhanced specificity and binding, and reduced toxicity
David Rabuka Chem

Global Head of R&D, Chemical Biology

Catalent Pharma Solutions

Dr. Anand Gautam

Director R&D Innovation Sourcing

Novo Nordisk



Sponsors and Partners




Media partner